Loading...

Spruce Biosciences ($SPRB)

Stock Image

SPRB Overview

Spruce Biosciences, a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders.The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH.It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses.Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California. (From: StockAnalysis.com)

MORE ABOUT Spruce Biosciences

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.

CONVERSATIONS ABOUT Spruce Biosciences